All Articles, News & Resources

Search, filter, and explore articles, updates, and tools that support better oversight.

Scroll

All Articles, News & Resources

Search, filter, and explore articles, updates, and tools that support better oversight.

Cyntegrity logo – Risk-Based Quality Management Solutions

Trending Now: Most-Read by Clinical Teams

Trending Now: Most-Read by Clinical Teams

FDA Warning Letter Highlights AI Oversight Risks in Clinical Trials

FDA’s warning letter signals a shift: AI use without oversight is a compliance risk. What

ICH E6(R3) Sponsor Responsibilities: What’s New and What It Means for You

Understand sponsor responsibilities under ICH E6(R3) and how to meet modern GCP expectations using risk-based,

5 Key Questions to Ask When Evaluating RBQM Platforms (ICH E6(R3)-Ready)

Learn the 5 essential evaluation questions when comparing RBQM systems. Ensure transparency, traceability, collaboration, and

Quality Tolerance Limits (QTLs) in Clinical Trials

Quality tolerance limits (QTLs) define when trial performance risks safety or data integrity. This guide

Service Level Availability – SLA

Service Level Availability or “SLA” means the targeted availability levels measured in the Production environment, as specified in the SaaS Listing which may vary according to each SaaS Offering and its component capabilities....

AI Literacy in Clinical Trials Under ICH E6(R3)

AI-supported workflows in clinical trials increasingly fall within GCP, computerized system, data integrity, and AI governance expectations. Sponsors and CROs need teams that understand oversight, validation, accountability, and responsible AI use....

FDA Warning Letter Highlights AI Oversight Risks in Clinical Trials

FDA’s warning letter signals a shift: AI use without oversight is a compliance risk. What clinical trial teams must understand to stay inspection-ready....

Global Uncertainty and Clinical Research: Why a Risk-Based Perspective Matters

Global risks in clinical trials are increasing as geopolitical instability, supply chain disruptions, and regulatory changes affect research worldwide. Learn why RBQM is essential for proactive oversight....

All Articles News & Resources

These pages are meant to:
Attract talent aligned with your mission and additionally mindset.
Show that Cyntegrity is a company people want to work with — especially and work for.
but, Provide assurance to enterprise clients that you align with modern values (ESG, ethics, diversity).

INDUSTRY SOLUTIONS page is focused on regulatory assurance, and especially its goal is to build trust. And remove perceived risk from decision-makers like Project, Program, Operations leads, QA leads, regulatory officers, clinical compliance managers, and procurement teams.

Trusted Compliance page is focused on regulatory assurance, and additionally its goal is to build trust and remove perceived risk from decision-makers. like QA leads, regulatory officers, clinical compliance managers, and procurement teams, but.

Key Capabilities pages are meant to tease our technical and especially operational capabilities, but not overwhelm. but, They should:
Show how it works, Prove interoperability, Make it easy to request technical info (not deliver it all upfront)

Connect & Deploy – These are deeper technical capabilities. Visitors here are:
Clinical data leads.
IT/integration specialists.
Ops leaders trying to understand if your platform plugs into theirs.
These pages also must communicate technical readiness but still follow your “teaser-first. CTA-driven” rule — no docs, SDKs, or especially schemas upfront.

Compliance Snapshot pages are all about building trust and especially accelerating vendor approval. Their job is to reassure IT security leads, QA managers. And procurement that Cyntegrity is fully compliant, auditable, and secure especially.
These are not product pages — they are trust assets. Also They should be simple, scannable, and downloadable especially.
These are not sales pages — also, they are trust accelerators for decision-makers who ask.
“Is this vendor secure, validated, and certified?”

All Articles News & Resources

AI Use in Clinical Trials Is Increasing.
So Are Regulatory Expectations.

Regulators expect controlled, documented, and reviewable AI use. Prepare your teams to apply AI within GCP and computerized system requirements.